Evaluation of the Accelerate Pheno System for Rapid Identification and Antimicrobial Susceptibility Testing of Positive Blood Culture Bottles Inoculated with Primary Sterile Specimens from Patients with Suspected Severe Infections.


Journal

Journal of clinical microbiology
ISSN: 1098-660X
Titre abrégé: J Clin Microbiol
Pays: United States
ID NLM: 7505564

Informations de publication

Date de publication:
20 04 2021
Historique:
received: 22 10 2020
accepted: 05 02 2021
pubmed: 12 2 2021
medline: 9 7 2021
entrez: 11 2 2021
Statut: epublish

Résumé

The Accelerate Pheno system is approved for rapid identification and phenotypic antimicrobial susceptibility testing (AST) of microorganisms grown from positive blood cultures inoculated with blood from septic patients. We evaluated the performance of the system for identification and AST from positive blood culture bottles inoculated with primary sterile nonblood specimens from patients with suspected severe infections. One hundred positive blood culture bottles with primary sterile specimens (63 cerebrospinal fluids, 16 ascites, 7 pleural fluids, 4 vitreous fluids, 5 joint aspirates, and 5 other aspirates) from 100 patients were included. Pathogen identification was in agreement with conventional methods for 72 of 100 cultures (72%) and for 81 of 112 (72%) pathogens when considering all pathogens and for 72 of 92 (78%) cultures and 81 of 104 (78%) pathogens when considering on-panel pathogens only. Eight of 31 isolates (26%) not identified by APS were pathogens not included in the APS panel. APS and conventional methods accordingly identified all pathogens from two of nine polymicrobial cultures (22%). APS generated antimicrobial resistance results for 57 pathogens of 57 cultures. The overall category agreement between APS and culture-based AST was 91.2%; and the rate for minor errors was 6.9%, for major was 1.7%, and for very major errors was 0.2%. APS may accelerate pathogen identification and phenotypic AST from positive blood culture bottles inoculated with primary sterile specimens from patients with serious infections, especially for hospitals without an on-site microbiology laboratory. However, the inclusion of nonblood specimens with a high likelihood of polymicrobial infections may result in an inferior performance.

Identifiants

pubmed: 33568464
pii: JCM.02637-20
doi: 10.1128/JCM.02637-20
pmc: PMC8091844
pii:
doi:

Substances chimiques

Anti-Bacterial Agents 0
Anti-Infective Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2021 American Society for Microbiology.

Références

Eur J Clin Microbiol Infect Dis. 2021 Jan;40(1):151-157
pubmed: 32860091
Clin Orthop Relat Res. 2010 Aug;468(8):2238-43
pubmed: 20162386
J Antimicrob Chemother. 2018 Jun 1;73(6):1546-1552
pubmed: 29474660
Ann Rheum Dis. 2007 Apr;66(4):440-5
pubmed: 17223664
BMC Infect Dis. 2016 Aug 09;16:392
pubmed: 27507415
J Clin Microbiol. 2016 Dec;54(12):3043-3049
pubmed: 27733637
Thorax. 2011 Aug;66(8):658-62
pubmed: 21459855
QJM. 2005 Apr;98(4):291-8
pubmed: 15760921
Clin Infect Dis. 2017 Jan 1;64(1):15-23
pubmed: 27678085
Eye (Lond). 2011 Aug;25(8):1069-73
pubmed: 21681212
Antimicrob Agents Chemother. 2010 Oct;54(10):4085-91
pubmed: 20660675
J Clin Microbiol. 2016 Nov;54(11):2837-2840
pubmed: 27629894
J Clin Microbiol. 2017 Jul;55(7):2116-2126
pubmed: 28446572
J Clin Microbiol. 2018 Mar 26;56(4):
pubmed: 29386262
J Am Geriatr Soc. 2014 Feb;62(2):306-11
pubmed: 24438554
J Clin Microbiol. 2017 Dec 26;56(1):
pubmed: 29118168
Eur J Clin Microbiol Infect Dis. 2018 May;37(5):889-895
pubmed: 29318458
Arch Pathol Lab Med. 2013 Sep;137(9):1247-54
pubmed: 23216247
Crit Care Med. 2006 Jun;34(6):1589-96
pubmed: 16625125
J Appl Lab Med. 2019 Jan;3(4):569-579
pubmed: 31639726

Auteurs

V Chapot (V)

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

L Effenberg (L)

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

J Dohmen-Ruetten (J)

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

J Buer (J)

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany.

J Kehrmann (J)

Institute of Medical Microbiology, University Hospital Essen, University of Duisburg-Essen, Essen, Germany jan.kehrmann@uk-essen.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH